Evidence map›Paper›PMID 31748321›Full record

ArticleJournal of clinical microbiology2020

Optimal Timing of Repeat Multiplex Molecular Testing for Respiratory Viruses.

Yamini Mandelia, Gary W Procop, Sandra S Richter, Sarah Worley, Wei Liu, Frank Esper

Abstract read
In one paragraph

Article in Journal of clinical microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Panels and Syndromic Testing in Clinical Microbiology.Clinics in laboratory medicine · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yamini MandeliaCenter for Pediatric Infectious Diseases, Cleveland Clinic, Cleveland, Ohio, USA mandely@ccf.org esperf@ccf.org.
Gary W ProcopDepartment of Laboratory Medicine, Cleveland Clinic, Cleveland, Ohio, USA.
Sandra S RichterDepartment of Laboratory Medicine, Cleveland Clinic, Cleveland, Ohio, USA.
Sarah WorleyDepartment of Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio, USA.
Wei LiuDepartment of Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio, USA.
Frank EsperCenter for Pediatric Infectious Diseases, Cleveland Clinic, Cleveland, Ohio, USA mandely@ccf.org esperf@ccf.org.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Determining whether and when multiplex nucleic acid amplification tests (NAATs) for respiratory viruses should be repeated is difficult. We analyzed 5 years of results for a multiplex NAAT targeting 14 respiratory viruses, to determine how often repeat tests were ordered and the time period in which results were likely to change. Results for NAATs performed on nasopharyngeal specimens and repeated within 90 days after initial testing were analyzed. Logistic regression models were used to compare time periods between tests with respect to the odds of a change in the sample result. During the study period, 21,819 nasopharyngeal specimens from 16,779 individuals were submitted. Of these, 8,807 samples (40%) were positive for at least one viral pathogen. Among this cohort, 2,583 specimens (12%) collected from 1,473 patients (9%) were repeat tests performed within 90 days after an initial test. If repeated within 90 days, 71% of tests (1,833 tests) did not have a change in result. Initially negative tests typically remained negative, whereas initially positive tests mostly remained positive until 11 to 15 days. The odds of result change plateaued after 20 days. The odds of result change for tests repeated within 20 days were only 0.52 times the odds (95% confidence interval, 0.43 to 0.62) for those repeated at 21 to 90 days (

Indexed as

AdultChild, PreschoolCohort StudiesCommunity-Acquired InfectionsHumansInfantInfluenza A virusLogistic ModelsMiddle AgedMolecular Diagnostic TechniquesMultiplex Polymerase Chain ReactionNasopharynxRespiratory Syncytial VirusesRespiratory Tract InfectionsTime FactorsVirusescommunity-acquired pneumoniainfluenzalaboratory stewardshipmultiplex PCRNAATpneumoniarepeat testingrespiratory syncytial virusrespiratory viral panelrespiratory viruses

Identifiers

PMID31748321
PMCPMC6989085

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.